Sleep-walking with Zolpidem: Need for Continued Postmarketing Surveillance

The Food and Drug Administration issued a request to drug manufacturers to include these warnings in the labels of drugs approved for the treatment of insomnia in December 2006.

Saved in:
Bibliographic Details
Published inIndian journal of psychological medicine Vol. 37; no. 4; pp. 476 - 477
Main Authors Sharma, Ajitha, Prakasha S., Rama
Format Journal Article
LanguageEnglish
Published New Delhi, India SAGE Publications 01.10.2015
Sage Publications Ltd. (UK)
Sage Publications, New Delhi India
Medknow Publications & Media Pvt Ltd
SAGE Publishing
Subjects
GABA
Letter to Editor
Pharmaceutical industry
Side effects
Sleep
Sleepwalking
Surveillance
Online AccessGet full text

Cover

More Information
Summary:The Food and Drug Administration issued a request to drug manufacturers to include these warnings in the labels of drugs approved for the treatment of insomnia in December 2006.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0253-7176
0975-1564
DOI:10.4103/0253-7176.168617